The global over-the-counter (OTC) pain relief market, valued at USD 28.6 billion in 2022, is projected to reach USD 40.93 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2032. This growth is driven by increasing consumer preference for self-care solutions and a growing elderly population seeking convenient pain management options.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5076
OTC Pain Relief Market: Driven by Aging Population and Rising Demand for Self-Care
The over-the-counter (OTC) analgesic market is witnessing significant growth, largely fueled by the increasing number of senior citizens who are turning to OTC pain relievers for managing chronic conditions. In 2019 alone, around 94,820 elderly individuals were prescribed at least one analgesic medication. As the global population ages, the demand for OTC pain relief continues to rise, driven by the high prevalence of chronic pain and the increasing desire for self-care solutions.
Pain Relief Usage Across Age Groups
Among the elderly, OTC analgesics like salicylates and acetaminophen are commonly used to manage chronic health issues such as joint pain, often linked to long-term conditions like arthritis. As public awareness about these health concerns grows, so does the demand for pain relief products. However, as these conditions require different types of analgesics, the market continues to evolve, with growing interest in alternatives to prescription medications.
In addition to common OTC options, older adults also frequently use non-steroidal anti-inflammatory drugs (NSAIDs) and, in some cases, weaker opioids. Self-medication, particularly through OTC pain relief from local pharmacies, has become a preferred option for managing multiple health issues and comorbidities among seniors.
The demand for OTC analgesics is therefore expanding, as more seniors seek accessible pain relief alternatives. This growth presents an opportunity for companies to tailor their offerings to meet the unique needs of this demographic, ensuring that solutions are not only effective but also easily accessible.
A Surge in OTC Pain Relief During the COVID-19 Pandemic
The COVID-19 pandemic further highlighted the need for accessible pain relief, with many elderly individuals choosing OTC analgesics over hospital visits. In 2020, the European Medicines Agency (EMA) recommended the use of common OTC analgesics like NSAIDs, paracetamol, and ibuprofen to manage mild symptoms of COVID-19. This advice, coupled with rising self-medication trends, has helped drive the growth of the OTC analgesic market.
The World Health Organization (WHO) reported in 2021 that over 296 million people (5.8% of the global population) between the ages of 15 and 64 had used drugs at least once, with opioids accounting for about 60 million users. These figures underscore the ongoing demand for pain relief solutions, with OTC medications often being the first choice for pain management.
Concerns Over Safety and Overuse of OTC Analgesics
Despite their widespread use, there are growing concerns about the safety and potential overuse of OTC analgesics. The Centers for Disease Control and Prevention (CDC) estimates that overuse of these medications contributes to 115 deaths per day in the United States. While OTC pain relievers are generally considered safe, excessive use—particularly for chronic pain or emotional distress—can lead to serious health issues.
In fact, overuse is associated with conditions like depression, as many individuals turn to analgesics to cope with mood disturbances or insomnia. Abuse of OTC analgesics, such as exceeding the recommended daily dose of acetylsalicylic acid (ASA) or acetaminophen, can lead to more severe health complications. This has prompted experts to emphasize the need for public education on the risks of overusing these medications and the importance of seeking alternative pain management strategies.
Key Drivers of Growth in the OTC Pain Relief Market
Several types of OTC pain relievers are driving market growth. Acetaminophen, often recommended for joint pain and other mild-to-moderate conditions, is a go-to option for many due to its safety and effectiveness. Non-steroidal anti-inflammatory drugs (NSAIDs) are also in high demand, particularly for chronic pain management, including conditions like arthritis and musculoskeletal injuries.
Salicylates, particularly aspirin, remain a key component in OTC analgesics, known for their anti-inflammatory and pain-relieving properties. The versatility of these medications makes them a staple in many households, contributing to the expansion of the market.
Recent Developments in the OTC Analgesic Market
The OTC analgesic market continues to innovate, with new products catering to diverse consumer needs. In January 2022, CV Sciences Inc. launched a line of OTC analgesics infused with hemp-derived CBD, offering a natural alternative for minor pain relief. In 2021, the FDA approved topical diclofenac as an OTC NSAID for treating knee osteoarthritis, further expanding available options for pain sufferers. Additionally, in March 2021, Hisamitsu America received FDA approval for the over-the-counter sale of Solanpas Arthritis Analgesic Gel, a clinically proven option for joint pain relief.
Leading Companies in the OTC Analgesic Market
Several major players dominate the OTC analgesic market, including:
- Bayer AG
- Boehringer Ingelheim International Gmb
- Johnson & Johnson
- Haleon PLC
- Novartis AG
- Dr. Reddy’s Laboratories Ltd
- Sanofi SA
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries Ltd
- Viatris Inc.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/over-the-counter-analgesics-market-size
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5076
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Visit Dental Specifics: https://www.towardsdental.com
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare